Chat with us, powered by LiveChat


Laparoscopic Tumor Ablation Market Report


Laparoscopic Tumor Ablation Market, by Technology Type (Microwave Ablation, Radiofrequency (RF) Ablation, Chemical Ablation, Cryotherapy, Others), Application (Orthopedic, Lung, Liver, Others), Regional Analysis (North America, Europe, Asia-Pacific, LAMEA): Global Opportunity Analysis and Industry Forecast, 2019–2026


Pages: NA

Dec 2019

Global Laparoscopic Tumor Ablation Market Overview 2026:

Laparoscopic ablation is a minimally invasive surgery, where surgery is performed with the support of a video camera and thin instruments. Laparoscopic tumor ablation is the process of elimination of tumors from the patients’ organs including bone, lungs, kidney, and liver. In this process, doctors inject thin instruments through the skin and remove the abnormal tissue with clod (Cryoablation) and heat (radiofrequency ablation).

Driving Factors: Increase in the aging population and cancer patients are the major driving factors for the growth of the laparoscopic tumor market.

Growing aged population along with rise in the number of cancer patients across the globe and upsurge in the number of ablation centers, hospitals and clinics are the significant laparoscopic tumor ablation market drivers. In addition, growing cancer cases across the globe are impacting the growth of the laparoscopic tumor ablation market. Also, growing incidence of cancer diseases globally is forcing a high economic investment on the countries. Thus, governments are implementing initiatives to create awareness among the people about cancer and increasing healthcare investments for the adoption of advanced treatment and diagnosis methods in hospitals, clinics and other institutions.   These factors will enhance the demand for the laparoscopic tumor ablation devices across the world. As per approximation by World Health Organization (WHO), the number of global cancer patients could rise, and around 13% of the global population pose a risk of suffering from cancer. Moreover, growing demand for laparoscopic ablation devices from hospitals, ablation centers and research laboratories for the diagnosis of cancer for the treatment of the patients will drive the market growth. 

Growing innovations in the technology and increase in the minimally invasive procedures are anticipated to create significant investment opportunities for the growth of laparoscopic tumor ablation market.

Continuous advancements in the laparoscopic technology coupled with growing number of patients taking minimally invasive procedures are generating substantial growth opportunities in the laparoscopic tumor ablation market. In addition, rising awareness about laparoscopic ablations process over conventional surgical and therapeutic procedures is anticipated to drive the market growth in the coming years. Also, increase in the demand for laparoscopic ablation devices from the ablation centers, medical research laboratories and hospitals is forcing the manufacturers to produce advanced systems and this is projected to impel the laparoscopic tumor ablation market growth. 

Microwave ablation technology type is predicted to be most lucrative in the estimated time

Radiofrequency (RF) ablation held the significant laparoscopic tumor ablation market share in 2018 and is anticipated to continue its growth in the market share during the projected time. This growth is majorly because of wide usage of RF ablation in the hospitals and ablation centers due to various advantages such as efficiency, less risk to the patient, minimally invasive procedure with no skin incision and others. In addition, growing improvements and commercialization of technically advanced RF ablations systems are projected to enhance the growth of the laparoscopic tumor ablation market. Also, according to National Center for Biotechnology Information (NCBI), the success rate of RF ablation and microwave ablation systems in the removal of tumors in liver is around 80% and reoccurrence of the tumor is also very less when compared to chemical ablation and chemotherapy. 
Along with RF ablation, microwave ablation will witness to grow at a notable rate during the forecast period. Microwave ablation is the thermal ablation technique for the treatment of tumors and uses electromagnetic waves from 300 MHz up to 300 GHz to remove the tumor by heating. This ablation procedure requires less treatment time and is reliable even at high temperature; these advantages of microwave ablation will enhance the growth of the market in the estimated time. 

Liver application registered for highest market size and is projected to grow with heath rate during the estimated time

Liver application is accounted for the highest laparoscopic tumor ablation market size in 2018 and is projected to experience significant growth during the estimated time. This growth is mainly due to extensive usage of laparoscopic ablation systems for the treatment of the liver cancer. In addition, growing prevalence of the liver cancer is anticipated to impel the growth of the market in the projected time. Lung laparoscopic tumor ablation market is predicted to experience a noteworthy growth during the forecast period. Growing instances of lung related diseases is expected to drive the market growth in the projected period. According to WHO, in 2018, cancer deaths across the globe were estimated to be 9.6 million, out of which 1.76 million deaths were due to lung cancer.  

Asia-Pacific region will have huge investment opportunities for the market investors to grow over the coming years.

Asia-Pacific is projected to experience a significant growth, and it is anticipated to generate substantial revenue in the laparoscopic tumor ablation market during the forecast period. This growth is majorly owing to growing cancer patient’s population and rise in the aging population in the Asia-Pacific region. Also, growing demand for laparoscopic ablation devices from invasive surgeries and increasing healthcare investments in this region are projected to drive the market size. In addition, rapidly developing economies including China, India, Australia and other countries are focusing on the healthcare infrastructure and several government initiatives across the Asia-Pacific region are increasing the demand for the laparoscopic tumor ablation market. For example, Indian government has taken initiative “National Cancer Grid” for uniform treatment of every cancer patient with the help of 177 institutions across the India. These factors are projected to propel the laparoscopic tumor ablation devices demand in the Asia-Pacific region. 
North America has dominated the global laparoscopic tumor ablation market share followed by Europe in 2018 and is predicted to command the market size in the projected period. This dominance is accredited to the presence of well-developed healthcare infrastructure in the major developed economies such as U.S., Canada and other countries in the North America region. Also, increase in the number of cancer patients across the region and increasing patients for invasive treatment for cancer detection and treatment is projected to rise the demand for laparoscopic tumor ablation devices will drive the market growth. 
To explore more about laparoscopic tumor ablation market, get in touch with our analysts here.

Key players in Global Laparoscopic Tumor Ablation Market:

Joint ventures and R&D investments are the most common approaches followed by the key players

Key players in Global Laparoscopic Tumor Ablation Market

Source: Research Dive Analysis

Major laparoscopic tumor ablation market players include Boston Scientific Corporation, EDAP TMS, Medtronic, Misonix, Sonacare Medical, AngioDynamics, BTG International Ltd, HealthTronics, Inc., Mermaid Medical, Inc., NeuWave Medical, Inc. and among many others. The players are focusing on the product developments, mergers & acquisitions, joint ventures, product launches and R&D investments to rise their position in the global laparoscopic tumor ablation industry.  




  Historical Market Estimations


  Base Year for Market Estimation


  Forecast timeline for Market Projection


  Geographical Scope

  North America, Europe, Asia-Pacific, LAMEA

  Segmentation by Technology Type

  • Microwave Ablation
  • Radiofrequency (RF) Ablation
  • Chemical Ablation
  • Cryotherapy
  • Others

  Segmentation by Application

  • Orthopedic
  • Lung
  • Liver
  • Others

  Key Countries Covered

U.S., Canada, Germany, France, Spain, Russia, Japan, China, India, South Korea, Australia, Brazil, and Saudi Arabia

  Key Companies Profiled

  • Boston Scientific Corporation
  • Medtronic
  • Misonix
  • Sonacare Medical
  • AngioDynamics
  • BTG International Ltd
  • HealthTronics, Inc.
  • Mermaid Medical, Inc.
  • NeuWave Medical, Inc.

Source: Research Dive Analysis

Frequently Asked Questions

A. Boston Scientific Corporation, EDAP TMS, Misonix, AngioDynamics, Mermaid Medical, Inc. and NeuWave Medical, Inc. are some of the leading companies in the global laparoscopic tumor ablation market.

A. Asia-Pacific possesses great investment opportunities for the investors to witness the most promising growth in the coming years.

A. Product development, and joint ventures are the key strategies opted by the operating companies in this market.

A. Boston Scientific Corporation, AngioDynamics and BTG International Ltd are investing more on R&D activities for developing new products and technologies.

Research Methodology

Purchase Options

Personalize this research

  • Triangulate with your own data
  • Request your format and definition
  • Get a deeper dive on a specific application, geography, customer or competitor
10% Off on Customization
Contact Us

Customers Also Viewed